COSAN SA -ADR (CSAN)

US22113B1035 - ADR

5.35  -0.05 (-0.93%)

Fundamental Rating

4

Taking everything into account, CSAN scores 4 out of 10 in our fundamental rating. CSAN was compared to 205 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and financial health of CSAN have multiple concerns. CSAN is valued quite cheap, while showing a decent growth score. This is a good combination!



3

1. Profitability

1.1 Basic Checks

CSAN had positive earnings in the past year.
CSAN had a positive operating cash flow in the past year.
In the past 5 years CSAN has always been profitable.
In the past 5 years CSAN always reported a positive cash flow from operatings.

1.2 Ratios

CSAN has a worse Return On Assets (1.54%) than 71.14% of its industry peers.
CSAN's Return On Equity of 11.22% is in line compared to the rest of the industry. CSAN outperforms 49.75% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.25%, CSAN is doing worse than 71.64% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CSAN is significantly below the industry average of 29.03%.
Industry RankSector Rank
ROA 1.54%
ROE 11.22%
ROIC 3.25%
ROA(3y)2.64%
ROA(5y)3.54%
ROE(3y)17.49%
ROE(5y)16.66%
ROIC(3y)4%
ROIC(5y)4.83%

1.3 Margins

CSAN has a Profit Margin of 5.36%. This is in the lower half of the industry: CSAN underperforms 64.18% of its industry peers.
CSAN's Profit Margin has declined in the last couple of years.
The Operating Margin of CSAN (12.61%) is worse than 62.19% of its industry peers.
In the last couple of years the Operating Margin of CSAN has grown nicely.
With a Gross Margin value of 30.06%, CSAN is not doing good in the industry: 60.70% of the companies in the same industry are doing better.
CSAN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.61%
PM (TTM) 5.36%
GM 30.06%
OM growth 3Y13.76%
OM growth 5Y11.76%
PM growth 3Y-23.96%
PM growth 5Y-29.62%
GM growth 3Y0.4%
GM growth 5Y1.77%

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CSAN is destroying value.
CSAN has about the same amout of shares outstanding than it did 1 year ago.
CSAN has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CSAN is higher compared to a year ago.

2.2 Solvency

CSAN has an Altman-Z score of 0.71. This is a bad value and indicates that CSAN is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CSAN (0.71) is worse than 66.67% of its industry peers.
CSAN has a debt to FCF ratio of 15.71. This is a negative value and a sign of low solvency as CSAN would need 15.71 years to pay back of all of its debts.
CSAN has a Debt to FCF ratio of 15.71. This is in the lower half of the industry: CSAN underperforms 60.70% of its industry peers.
CSAN has a Debt/Equity ratio of 3.15. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CSAN (3.15) is worse than 89.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.15
Debt/FCF 15.71
Altman-Z 0.71
ROIC/WACC0.37
WACC8.81%

2.3 Liquidity

A Current Ratio of 1.86 indicates that CSAN should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.86, CSAN is doing good in the industry, outperforming 71.64% of the companies in the same industry.
A Quick Ratio of 1.73 indicates that CSAN should not have too much problems paying its short term obligations.
CSAN's Quick ratio of 1.73 is fine compared to the rest of the industry. CSAN outperforms 72.64% of its industry peers.
Industry RankSector Rank
Current Ratio 1.86
Quick Ratio 1.73

6

3. Growth

3.1 Past

CSAN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 155.71%, which is quite impressive.
Measured over the past years, CSAN shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.55% on average per year.
Looking at the last year, CSAN shows a small growth in Revenue. The Revenue has grown by 2.72% in the last year.
CSAN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 30.85% yearly.
EPS 1Y (TTM)155.71%
EPS 3Y1.66%
EPS 5Y-6.55%
EPS Q2Q%15.38%
Revenue 1Y (TTM)2.72%
Revenue growth 3Y42.96%
Revenue growth 5Y30.85%
Sales Q2Q%-70.54%

3.2 Future

The Earnings Per Share is expected to grow by 66.01% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 5.69% on average over the next years.
EPS Next Y22.38%
EPS Next 2Y97.91%
EPS Next 3Y66.01%
EPS Next 5YN/A
Revenue Next Year7.34%
Revenue Next 2Y3.58%
Revenue Next 3Y3.92%
Revenue Next 5Y5.69%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

8

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.38, which indicates a very decent valuation of CSAN.
CSAN's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.34. CSAN is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 3.65, the valuation of CSAN can be described as very cheap.
Based on the Price/Forward Earnings ratio, CSAN is valued cheaper than 94.53% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.61, CSAN is valued rather cheaply.
Industry RankSector Rank
PE 11.38
Fwd PE 3.65

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CSAN is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CSAN indicates a rather cheap valuation: CSAN is cheaper than 91.54% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 3.51
EV/EBITDA 6.59

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CSAN's earnings are expected to grow with 66.01% in the coming years.
PEG (NY)0.51
PEG (5Y)N/A
EPS Next 2Y97.91%
EPS Next 3Y66.01%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.63%, CSAN is a good candidate for dividend investing.
In the last 3 months the price of CSAN has falen by -37.35%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
CSAN's Dividend Yield is a higher than the industry average which is at 6.70.
CSAN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 5.63%

5.2 History

On average, the dividend of CSAN grows each year by 16.15%, which is quite nice.
CSAN has been paying a dividend for over 5 years, so it has already some track record.
The dividend of CSAN decreased recently.
Dividend Growth(5Y)16.15%
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

CSAN pays out 167.30% of its income as dividend. This is not a sustainable payout ratio.
The dividend of CSAN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP167.3%
EPS Next 2Y97.91%
EPS Next 3Y66.01%

COSAN SA -ADR

NYSE:CSAN (1/10/2025, 10:13:00 AM)

5.35

-0.05 (-0.93%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)N/A N/A
Inst Owners34.07%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.49B
Analysts78.82
Price Target7.74 (44.67%)
Short Float %0.12%
Short Ratio1.65
Dividend
Industry RankSector Rank
Dividend Yield 5.63%
Dividend Growth(5Y)16.15%
DP167.3%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-49.23%
Min EPS beat(2)-69.01%
Max EPS beat(2)-29.45%
EPS beat(4)1
Avg EPS beat(4)0.67%
Min EPS beat(4)-218.45%
Max EPS beat(4)319.61%
EPS beat(8)2
Avg EPS beat(8)-16.76%
EPS beat(12)3
Avg EPS beat(12)-23.17%
EPS beat(16)6
Avg EPS beat(16)-7.26%
Revenue beat(2)0
Avg Revenue beat(2)-72.16%
Min Revenue beat(2)-72.24%
Max Revenue beat(2)-72.08%
Revenue beat(4)0
Avg Revenue beat(4)-54.49%
Min Revenue beat(4)-73.1%
Max Revenue beat(4)-0.53%
Revenue beat(8)0
Avg Revenue beat(8)-39.99%
Revenue beat(12)0
Avg Revenue beat(12)-51.88%
Revenue beat(16)0
Avg Revenue beat(16)-58.16%
PT rev (1m)-22.56%
PT rev (3m)-30.04%
EPS NQ rev (1m)-0.1%
EPS NQ rev (3m)-2.88%
EPS NY rev (1m)-0.1%
EPS NY rev (3m)-44.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.39%
Valuation
Industry RankSector Rank
PE 11.38
Fwd PE 3.65
P/S 0.36
P/FCF 3.51
P/OCF 1.34
P/B 0.76
P/tB N/A
EV/EBITDA 6.59
EPS(TTM)0.47
EY8.79%
EPS(NY)1.46
Fwd EY27.38%
FCF(TTM)1.53
FCFY28.51%
OCF(TTM)3.99
OCFY74.62%
SpS14.67
BVpS7
TBVpS-2.12
PEG (NY)0.51
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.54%
ROE 11.22%
ROCE 4.12%
ROIC 3.25%
ROICexc 3.83%
ROICexgc 5.03%
OM 12.61%
PM (TTM) 5.36%
GM 30.06%
FCFM 10.4%
ROA(3y)2.64%
ROA(5y)3.54%
ROE(3y)17.49%
ROE(5y)16.66%
ROIC(3y)4%
ROIC(5y)4.83%
ROICexc(3y)4.82%
ROICexc(5y)6.32%
ROICexgc(3y)6.29%
ROICexgc(5y)10.57%
ROCE(3y)5.06%
ROCE(5y)6.11%
ROICexcg growth 3Y-15.68%
ROICexcg growth 5Y-3.13%
ROICexc growth 3Y-4.17%
ROICexc growth 5Y5.13%
OM growth 3Y13.76%
OM growth 5Y11.76%
PM growth 3Y-23.96%
PM growth 5Y-29.62%
GM growth 3Y0.4%
GM growth 5Y1.77%
F-Score7
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 3.15
Debt/FCF 15.71
Debt/EBITDA 6.93
Cap/Depr 185.38%
Cap/Sales 16.82%
Interest Coverage 1.05
Cash Conversion 125.55%
Profit Quality 194.19%
Current Ratio 1.86
Quick Ratio 1.73
Altman-Z 0.71
F-Score7
WACC8.81%
ROIC/WACC0.37
Cap/Depr(3y)173.22%
Cap/Depr(5y)166.46%
Cap/Sales(3y)14.58%
Cap/Sales(5y)11.51%
Profit Quality(3y)282.6%
Profit Quality(5y)211.55%
High Growth Momentum
Growth
EPS 1Y (TTM)155.71%
EPS 3Y1.66%
EPS 5Y-6.55%
EPS Q2Q%15.38%
EPS Next Y22.38%
EPS Next 2Y97.91%
EPS Next 3Y66.01%
EPS Next 5YN/A
Revenue 1Y (TTM)2.72%
Revenue growth 3Y42.96%
Revenue growth 5Y30.85%
Sales Q2Q%-70.54%
Revenue Next Year7.34%
Revenue Next 2Y3.58%
Revenue Next 3Y3.92%
Revenue Next 5Y5.69%
EBIT growth 1Y-34.8%
EBIT growth 3Y62.64%
EBIT growth 5Y46.23%
EBIT Next Year80.74%
EBIT Next 3Y27.76%
EBIT Next 5Y22.42%
FCF growth 1Y-0.94%
FCF growth 3Y54.34%
FCF growth 5Y14.22%
OCF growth 1Y29%
OCF growth 3Y68.64%
OCF growth 5Y30.71%